Table of Content

1 Preventable Vaccines Market Overview
1.1 Preventable Vaccines Product Overview
1.2 Preventable Vaccines Market Segment by Type
1.2.1 Adult Preventable Vaccines
1.2.2 Pediatric Preventable Vaccines
1.3 Global Preventable Vaccines Market Size by Type
1.3.1 Global Preventable Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Preventable Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Preventable Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Preventable Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Preventable Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Preventable Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Type (2018-2024)
2 Global Preventable Vaccines Market Competition by Company
2.1 Global Top Players by Preventable Vaccines Sales (2018-2024)
2.2 Global Top Players by Preventable Vaccines Revenue (2018-2024)
2.3 Global Top Players by Preventable Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Preventable Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Preventable Vaccines Market Competitive Situation and Trends
2.5.1 Preventable Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Preventable Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Preventable Vaccines Market
2.8 Key Manufacturers Preventable Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Preventable Vaccines Status and Outlook by Region
3.1 Global Preventable Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Preventable Vaccines Historic Market Size by Region
3.2.1 Global Preventable Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Preventable Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Preventable Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Preventable Vaccines Forecasted Market Size by Region
3.3.1 Global Preventable Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Preventable Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Preventable Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Preventable Vaccines by Application
4.1 Preventable Vaccines Market Segment by Application
4.1.1 Bacterial Diseases
4.1.2 Virus Diseases
4.2 Global Preventable Vaccines Market Size by Application
4.2.1 Global Preventable Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Preventable Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Preventable Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Preventable Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Preventable Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Preventable Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Application (2018-2024)
5 North America Preventable Vaccines by Country
5.1 North America Preventable Vaccines Historic Market Size by Country
5.1.1 North America Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Preventable Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Preventable Vaccines Sales in Value by Country (2018-2024)
5.2 North America Preventable Vaccines Forecasted Market Size by Country
5.2.1 North America Preventable Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Preventable Vaccines Sales in Value by Country (2024-2034)
6 Europe Preventable Vaccines by Country
6.1 Europe Preventable Vaccines Historic Market Size by Country
6.1.1 Europe Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Preventable Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Preventable Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Preventable Vaccines Forecasted Market Size by Country
6.2.1 Europe Preventable Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Preventable Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Preventable Vaccines by Region
7.1 Asia-Pacific Preventable Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Preventable Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Preventable Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Preventable Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Preventable Vaccines Sales in Value by Region (2024-2034)
8 Latin America Preventable Vaccines by Country
8.1 Latin America Preventable Vaccines Historic Market Size by Country
8.1.1 Latin America Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Preventable Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Preventable Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Preventable Vaccines Forecasted Market Size by Country
8.2.1 Latin America Preventable Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Preventable Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Preventable Vaccines by Country
9.1 Middle East and Africa Preventable Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Preventable Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Preventable Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Preventable Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Preventable Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Preventable Vaccines Products Offered
10.3.5 Novartis Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Preventable Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sanofi Preventable Vaccines Products Offered
10.5.5 Sanofi Recent Development
10.6 Takeda Pharmaceutical
10.6.1 Takeda Pharmaceutical Company Information
10.6.2 Takeda Pharmaceutical Introduction and Business Overview
10.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
10.6.5 Takeda Pharmaceutical Recent Development
10.7 Abbott
10.7.1 Abbott Company Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbott Preventable Vaccines Products Offered
10.7.5 Abbott Recent Development
10.8 Roche
10.8.1 Roche Company Information
10.8.2 Roche Introduction and Business Overview
10.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Roche Preventable Vaccines Products Offered
10.8.5 Roche Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 AstraZeneca Preventable Vaccines Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Mitsubishi Tanabe Pharma
10.10.1 Mitsubishi Tanabe Pharma Company Information
10.10.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
10.10.5 Mitsubishi Tanabe Pharma Recent Development
10.11 Lupin
10.11.1 Lupin Company Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lupin Preventable Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 Serum Institute of India
10.12.1 Serum Institute of India Company Information
10.12.2 Serum Institute of India Introduction and Business Overview
10.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Serum Institute of India Preventable Vaccines Products Offered
10.12.5 Serum Institute of India Recent Development
10.13 LG Life Sciences
10.13.1 LG Life Sciences Company Information
10.13.2 LG Life Sciences Introduction and Business Overview
10.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 LG Life Sciences Preventable Vaccines Products Offered
10.13.5 LG Life Sciences Recent Development
10.14 S K Chemicals
10.14.1 S K Chemicals Company Information
10.14.2 S K Chemicals Introduction and Business Overview
10.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 S K Chemicals Preventable Vaccines Products Offered
10.14.5 S K Chemicals Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Company Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Company Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sinovac Biotech Preventable Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Janssen Pharmaceuticals
10.17.1 Janssen Pharmaceuticals Company Information
10.17.2 Janssen Pharmaceuticals Introduction and Business Overview
10.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Janssen Pharmaceuticals Preventable Vaccines Products Offered
10.17.5 Janssen Pharmaceuticals Recent Development
10.18 Crucell
10.18.1 Crucell Company Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Crucell Preventable Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Company Information
10.19.2 Bavarian Nordic Introduction and Business Overview
10.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Bavarian Nordic Preventable Vaccines Products Offered
10.19.5 Bavarian Nordic Recent Development
10.20 Baxter
10.20.1 Baxter Company Information
10.20.2 Baxter Introduction and Business Overview
10.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Baxter Preventable Vaccines Products Offered
10.20.5 Baxter Recent Development
10.21 Bharat Biotech
10.21.1 Bharat Biotech Company Information
10.21.2 Bharat Biotech Introduction and Business Overview
10.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Bharat Biotech Preventable Vaccines Products Offered
10.21.5 Bharat Biotech Recent Development
10.22 Dynavax
10.22.1 Dynavax Company Information
10.22.2 Dynavax Introduction and Business Overview
10.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Dynavax Preventable Vaccines Products Offered
10.22.5 Dynavax Recent Development
10.23 Bausch Health
10.23.1 Bausch Health Company Information
10.23.2 Bausch Health Introduction and Business Overview
10.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Bausch Health Preventable Vaccines Products Offered
10.23.5 Bausch Health Recent Development
10.24 Protein Sciences
10.24.1 Protein Sciences Company Information
10.24.2 Protein Sciences Introduction and Business Overview
10.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Protein Sciences Preventable Vaccines Products Offered
10.24.5 Protein Sciences Recent Development
10.25 Panacea Biotec
10.25.1 Panacea Biotec Company Information
10.25.2 Panacea Biotec Introduction and Business Overview
10.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Panacea Biotec Preventable Vaccines Products Offered
10.25.5 Panacea Biotec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Preventable Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Preventable Vaccines Industrial Chain Analysis
11.4 Preventable Vaccines Market Dynamics
11.4.1 Preventable Vaccines Industry Trends
11.4.2 Preventable Vaccines Market Drivers
11.4.3 Preventable Vaccines Market Challenges
11.4.4 Preventable Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Preventable Vaccines Distributors
12.3 Preventable Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adult Preventable Vaccines
Table 2. Major Company of Pediatric Preventable Vaccines
Table 3. Global Preventable Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Preventable Vaccines Sales by Type (2018-2024) & (K Units)
Table 5. Global Preventable Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Preventable Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Preventable Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Preventable Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Preventable Vaccines Sales by Type (2024-2034) & (K Units)
Table 10. Global Preventable Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Preventable Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Preventable Vaccines Sales Market Share in Value by Type (2024-2034)
Table 13. Global Preventable Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Preventable Vaccines Sales by Type (2018-2024) & (K Units)
Table 15. North America Preventable Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Preventable Vaccines Sales (K Units) by Type (2018-2024)
Table 17. Europe Preventable Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Preventable Vaccines Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Preventable Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Preventable Vaccines Sales (K Units) by Type (2018-2024)
Table 21. Latin America Preventable Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Preventable Vaccines Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Preventable Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Preventable Vaccines Sales by Company (2018-2024) & (K Units)
Table 25. Global Preventable Vaccines Sales Share by Company (2018-2024)
Table 26. Global Preventable Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Preventable Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Preventable Vaccines Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Preventable Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Preventable Vaccines Market
Table 33. Key Manufacturers Preventable Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Preventable Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Preventable Vaccines Sales by Region (2018-2024) & (K Units)
Table 37. Global Preventable Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Preventable Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Preventable Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Preventable Vaccines Sales by Region (2024-2034) & (K Units)
Table 42. Global Preventable Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Preventable Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Preventable Vaccines Sales Market Share in Value by Region (2024-2034)
Table 45. Global Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Preventable Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Preventable Vaccines Sales by Application (2018-2024) & (K Units)
Table 48. Global Preventable Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Preventable Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Preventable Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Preventable Vaccines Sales by Application (2024-2034) & (K Units)
Table 53. Global Preventable Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Preventable Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Preventable Vaccines Sales Market Share in Value by Application (2024-2034)
Table 56. Global Preventable Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Preventable Vaccines Sales by Application (2018-2024) (K Units)
Table 58. North America Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Preventable Vaccines Sales by Application (2018-2024) (K Units)
Table 60. Europe Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Preventable Vaccines Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Preventable Vaccines Sales by Application (2018-2024) (K Units)
Table 64. Latin America Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Preventable Vaccines Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Preventable Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Preventable Vaccines Sales by Country (2018-2024) & (K Units)
Table 68. North America Preventable Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Preventable Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Preventable Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Preventable Vaccines Sales by Country (2024-2034) & (K Units)
Table 72. North America Preventable Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Preventable Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Preventable Vaccines Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Preventable Vaccines Sales by Country (2018-2024) & (K Units)
Table 76. Europe Preventable Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Preventable Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Preventable Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Preventable Vaccines Sales by Country (2024-2034) & (K Units)
Table 80. Europe Preventable Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Preventable Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Preventable Vaccines Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Preventable Vaccines Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Preventable Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Preventable Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Preventable Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Preventable Vaccines Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Preventable Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Preventable Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Preventable Vaccines Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Preventable Vaccines Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Preventable Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Preventable Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Preventable Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Preventable Vaccines Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Preventable Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Preventable Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Preventable Vaccines Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Preventable Vaccines Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Preventable Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Preventable Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Preventable Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Preventable Vaccines Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Preventable Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Preventable Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Preventable Vaccines Sales Market Share in Value by Country (2024-2034)
Table 107. GlaxoSmithKline Company Information
Table 108. GlaxoSmithKline Introduction and Business Overview
Table 109. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. GlaxoSmithKline Preventable Vaccines Product
Table 111. GlaxoSmithKline Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Merck Preventable Vaccines Product
Table 116. Merck Recent Development
Table 117. Novartis Company Information
Table 118. Novartis Introduction and Business Overview
Table 119. Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Novartis Preventable Vaccines Product
Table 121. Novartis Recent Development
Table 122. Pfizer Company Information
Table 123. Pfizer Introduction and Business Overview
Table 124. Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Preventable Vaccines Product
Table 126. Pfizer Recent Development
Table 127. Sanofi Company Information
Table 128. Sanofi Introduction and Business Overview
Table 129. Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Sanofi Preventable Vaccines Product
Table 131. Sanofi Recent Development
Table 132. Takeda Pharmaceutical Company Information
Table 133. Takeda Pharmaceutical Introduction and Business Overview
Table 134. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Takeda Pharmaceutical Preventable Vaccines Product
Table 136. Takeda Pharmaceutical Recent Development
Table 137. Abbott Company Information
Table 138. Abbott Introduction and Business Overview
Table 139. Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Abbott Preventable Vaccines Product
Table 141. Abbott Recent Development
Table 142. Roche Company Information
Table 143. Roche Introduction and Business Overview
Table 144. Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Roche Preventable Vaccines Product
Table 146. Roche Recent Development
Table 147. AstraZeneca Company Information
Table 148. AstraZeneca Introduction and Business Overview
Table 149. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. AstraZeneca Preventable Vaccines Product
Table 151. AstraZeneca Recent Development
Table 152. Mitsubishi Tanabe Pharma Company Information
Table 153. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 154. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Mitsubishi Tanabe Pharma Preventable Vaccines Product
Table 156. Mitsubishi Tanabe Pharma Recent Development
Table 157. Lupin Company Information
Table 158. Lupin Introduction and Business Overview
Table 159. Lupin Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Lupin Preventable Vaccines Product
Table 161. Lupin Recent Development
Table 162. Serum Institute of India Company Information
Table 163. Serum Institute of India Introduction and Business Overview
Table 164. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Serum Institute of India Preventable Vaccines Product
Table 166. Serum Institute of India Recent Development
Table 167. LG Life Sciences Company Information
Table 168. LG Life Sciences Introduction and Business Overview
Table 169. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. LG Life Sciences Preventable Vaccines Product
Table 171. LG Life Sciences Recent Development
Table 172. S K Chemicals Company Information
Table 173. S K Chemicals Introduction and Business Overview
Table 174. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. S K Chemicals Preventable Vaccines Product
Table 176. S K Chemicals Recent Development
Table 177. Shenzhen Kangtai Biological Products Company Information
Table 178. Shenzhen Kangtai Biological Products Introduction and Business Overview
Table 179. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Shenzhen Kangtai Biological Products Preventable Vaccines Product
Table 181. Shenzhen Kangtai Biological Products Recent Development
Table 182. Sinovac Biotech Company Information
Table 183. Sinovac Biotech Introduction and Business Overview
Table 184. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Sinovac Biotech Preventable Vaccines Product
Table 186. Sinovac Biotech Recent Development
Table 187. Janssen Pharmaceuticals Company Information
Table 188. Janssen Pharmaceuticals Introduction and Business Overview
Table 189. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Janssen Pharmaceuticals Preventable Vaccines Product
Table 191. Janssen Pharmaceuticals Recent Development
Table 192. Crucell Company Information
Table 193. Crucell Introduction and Business Overview
Table 194. Crucell Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 195. Crucell Preventable Vaccines Product
Table 196. Crucell Recent Development
Table 197. Bavarian Nordic Company Information
Table 198. Bavarian Nordic Introduction and Business Overview
Table 199. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 200. Bavarian Nordic Preventable Vaccines Product
Table 201. Bavarian Nordic Recent Development
Table 202. Baxter Company Information
Table 203. Baxter Introduction and Business Overview
Table 204. Baxter Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 205. Baxter Preventable Vaccines Product
Table 206. Baxter Recent Development
Table 207. Bharat Biotech Company Information
Table 208. Bharat Biotech Introduction and Business Overview
Table 209. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 210. Bharat Biotech Preventable Vaccines Product
Table 211. Bharat Biotech Recent Development
Table 212. Dynavax Company Information
Table 213. Dynavax Introduction and Business Overview
Table 214. Dynavax Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 215. Dynavax Preventable Vaccines Product
Table 216. Dynavax Recent Development
Table 217. Bausch Health Company Information
Table 218. Bausch Health Introduction and Business Overview
Table 219. Bausch Health Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 220. Bausch Health Preventable Vaccines Product
Table 221. Bausch Health Recent Development
Table 222. Protein Sciences Company Information
Table 223. Protein Sciences Introduction and Business Overview
Table 224. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 225. Protein Sciences Preventable Vaccines Product
Table 226. Protein Sciences Recent Development
Table 227. Panacea Biotec Introduction and Business Overview
Table 228. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 229. Panacea Biotec Preventable Vaccines Product
Table 230. Panacea Biotec Recent Development
Table 231. Panacea Biotec Company Information
Table 232. Key Raw Materials Lists
Table 233. Raw Materials Key Suppliers Lists
Table 234. Preventable Vaccines Market Trends
Table 235. Preventable Vaccines Market Drivers
Table 236. Preventable Vaccines Market Challenges
Table 237. Preventable Vaccines Market Restraints
Table 238. Preventable Vaccines Distributors List
Table 239. Preventable Vaccines Downstream Customers
Table 240. Research Programs/Design for This Report
Table 241. Key Data Information from Secondary Sources
Table 242. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventable Vaccines Product Picture
Figure 2. Global Preventable Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Preventable Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Preventable Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Adult Preventable Vaccines
Figure 6. Global Adult Preventable Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Pediatric Preventable Vaccines
Figure 8. Global Pediatric Preventable Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Preventable Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Preventable Vaccines Sales Market Share by Type in 2022 & 2034
Figure 11. North America Preventable Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Preventable Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Preventable Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Preventable Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Preventable Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Preventable Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Preventable Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Preventable Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Preventable Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Preventable Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Preventable Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Preventable Vaccines Revenue in 2022
Figure 23. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Bacterial Diseases
Figure 25. Global Bacterial Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Virus Diseases
Figure 27. Global Virus Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global Preventable Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Preventable Vaccines Sales Market Share by Application in 2022 & 2034
Figure 30. North America Preventable Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Preventable Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Preventable Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Preventable Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Preventable Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Preventable Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Preventable Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Preventable Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Preventable Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Preventable Vaccines Manufacturing Cost Structure
Figure 41. Preventable Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed